Study of FA12 peptide-modified PEGylated liposomal doxorubicin (PLD) as an effective ligand to target Muc1 in mice bearing C26 colon carcinoma: in silico, in vitro, and in vivo study.
Atefeh BiabangardAhmad AsoodehMahmoud Reza JaafariMohammad Mahdi Barati JozanPublished in: Expert opinion on drug delivery (2022)
FA12 peptide is a promising targeting ligand for PLD to treat cancers with a high level of Muc1 expression and merits further investigations.